Transplant Outcomes with Fludarabine and Melphalan in High Risk AML Patients By Donor Types
Year: 2020
Type: article
Study design: Observational Study
Source: Blood
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3097718157
